Janssen Injecting $176 Million into Irish Biomedicines Plant
Janssen Injecting $176 Million into Irish Biomedicines Plant
GALWAY, IRELAND--September 28, 2021--Written by Martin Lynch, European News
Editor for Industrial Info (Galway, Ireland)--Johnson & Johnson (NYSE:JNJ) (New Brunswick, New Jersey) subsidiary Janssen Sciences Ireland is pumping 150 million euro (US$176 million) into expanding its manufacturing biomedicines facility in Ringaskiddy, County Cork.
Within this article: Details plant expansion, investment, products produced, timeline, previous investment
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Novartis Axing 320 Jobs at Irish Manufacturing Plant
- Costa Rica's Alajuela Municipality Attracts Pharma Companies
- Alajuela continúa destacándose en inversiones de la industria farmacéutica ...
- Pharma-Bio Industry North American Project Starts Top $5 Billion in First Q...
- Beyond the Smoke Stacks: Texas Ropes in $4 Billion Pharma-Bio Investment